Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity

Details for Australian Patent Application No. 2005213449 (hide)

Owner The Trustees of Columbia University in the City of New York The La Jolla Institute for Allergy and Immunology UCSF Diabetes Center

Inventors Herold, Kevan; Bluestone, Jeffrey A.; Von Herrath, Mathias

Agent Spruson & Ferguson

Pub. Number AU-A-2005213449

PCT Pub. Number WO2005/076965

Priority 60/541,959 04.02.04 US

Filing date 4 February 2005

Wipo publication date 25 August 2005

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/076965 Priority application(s): WO2005/076965

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005213457-Chimeric VEGF peptides

2005213444-Back-contact solar cells and methods for fabrication